United Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio13.1810.4917.4320.4513.10
Forward P/E12.179.9313.5613.4511.39
P/S Ratio5.474.446.555.774.55
P/B Ratio2.441.732.642.461.99
Price/Tangible Book2.491.762.672.492.08
Price/FCF14.5813.8219.1020.389.69
Price/OCF11.8710.5715.7916.278.93
PEG Ratio1.0213.471.030.711.27
Enterprise Value Ratios
EV/Revenue4.012.664.864.173.19
EV/EBITDA7.605.009.059.537.33
EV/EBIT7.985.229.5210.227.94
EV/FCF10.698.2914.1914.716.80
Profitability & Returns
Return on Equity (ROE)0.19%0.18%0.17%0.13%0.17%
Return on Assets (ROA)0.12%0.11%0.11%0.09%0.09%
Return on Invested Capital (ROIC)0.31%0.28%0.27%0.21%0.21%
Return on Capital Employed (ROCE)0.22%0.19%0.17%0.14%0.14%
Leverage & Solvency Ratios
Debt/Equity0.050.120.170.200.24
Debt/EBITDA0.220.560.771.091.24
Debt/FCF0.310.941.211.681.15
Liquidity Ratios
Current Ratio5.254.419.857.616.70
Quick Ratio4.804.099.126.976.16
Efficiency Ratios
Asset Turnover0.400.350.340.340.35
Inventory Turnover2.302.411.551.361.20
Yield & Distribution Ratios
Earnings Yield0.08%0.10%0.06%0.05%0.08%
FCF Yield0.07%0.07%0.05%0.05%0.10%
Buyback Yield0.02%-0.02%-0.03%-0.06%-0.02%